The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy

The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy

Editorial summary Immune checkpoint blockade therapy can elicit robust and durable responses in a variety of cancer types. While many patients do not respond, recent reports highlight a distinct group of patients whose tumors undergo rapid growth, leading to progressive disease and poor outcome. In...

Full description

Bibliographic Details
Main Authors: Erich Sabio, Timothy A. Chan
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Genome Medicine
Subjects:
Immune checkpoint
Hyperprogression
Cancer
T cells
Antigen
Mutation
Online Access:http://link.springer.com/article/10.1186/s13073-019-0661-7

Internet

http://link.springer.com/article/10.1186/s13073-019-0661-7

Similar Items